Great Valley Advisor Group’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$541K Sell
2,029
-1
-0% -$271 0.01% 662
2025
Q4
$509K Sell
2,030
-170
-8% -$45.1K 0.01% 623
2025
Q3
$632K Sell
2,200
-30
-1% -$8.04K 0.01% 572
2025
Q2
$585K Sell
2,230
-97
-4% -$23.6K 0.01% 573
2025
Q1
$542K Sell
2,327
-100
-4% -$24.3K 0.01% 575
2024
Q4
$557K Sell
2,427
-35
-1% -$8.03K 0.01% 554
2024
Q3
$550K Buy
2,462
+135
+6% +$29.7K 0.01% 542
2024
Q2
$473K Buy
+2,327
New +$473K 0.01% 542

Other funds holding LH

Great Valley Advisor Group's LH Position: Q1 2026 in Review

Great Valley Advisor Group reduced its Labcorp (LH) stake by 0.05% in Q1 2026, selling an estimated $271 and leaving 2,029 shares worth $541K. The position accounts for 0.01% of the portfolio, ranked #662.

Great Valley Advisor Group first reported a position in LH in Q2 2024 and has held it in 8 quarters since. The position peaked at $632K in Q3 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Great Valley Advisor Group held 2,029 shares of Labcorp worth $541K as of Q1 2026.
  • Great Valley Advisor Group sold 1 Labcorp share in Q1 2026, an estimated $271.
  • Labcorp made up 0.01% of Great Valley Advisor Group's portfolio in Q1 2026, its #662 holding.
  • Great Valley Advisor Group first reported a position in Labcorp in Q2 2024 and has held it in 8 quarters since.
  • Great Valley Advisor Group's Labcorp position peaked at $632K in Q3 2025.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Great Valley Advisor Group's 13F filing for Q1 2026, filed 11 May 2026.